Close Menu
  • About
  • Products
    • Find Solutions
    • Technical Q&A
    • Novelty Search
    • Feasibility Analysis Assistant
    • Material Scout
    • Pharma Insights Advisor
    • More AI Agents For Innovation
  • IP
  • Machinery
  • Material
  • Life Science
Facebook YouTube LinkedIn
Eureka BlogEureka Blog
  • About
  • Products
    • Find Solutions
    • Technical Q&A
    • Novelty Search
    • Feasibility Analysis Assistant
    • Material Scout
    • Pharma Insights Advisor
    • More AI Agents For Innovation
  • IP
  • Machinery
  • Material
  • Life Science
Facebook YouTube LinkedIn
Patsnap eureka →
Eureka BlogEureka Blog
Patsnap eureka →
Home»Company»Who Is React Health Holdings, LLC? A 2025 Company Profile

Who Is React Health Holdings, LLC? A 2025 Company Profile

May 14, 20253 Mins Read
Share
Facebook Twitter LinkedIn Email

React Health Holdings, LLC is a fast-growing player in the medical technology space, specializing in respiratory and ventilator systems. With subsidiaries like Ventec Life Systems and a strong patent portfolio in patient circuit systems, the company is reshaping innovation in respiratory care.

This article explores React Health’s innovation footprint, patent strengths, and global strategy—powered by insights from the Discovery platform and PatSnap Eureka AI Agent.

Company Overview

AttributeInformation
Company NameReact Health Holdings, LLC
Founded2021
HeadquartersSarasota, Florida, United States
Legal AddressWilmington, Delaware, United States
Entity StatusActive
BusinessWholesales medical equipment
Subsidiaries2 (including Ventec Life Systems, Inc.)

Technology Focus

React Health’s patent landscape reveals strong specialization in:

  • Patient circuit and ventilator connection
  • Oxygen concentrators and assist devices
  • Cough assist systems and respiratory therapy
  • Gas separation and delivery systems

These keywords reflect a dedicated push toward respiratory innovation—particularly in medical ventilation and oxygen supply for chronic conditions and emergency response.

Patent & Innovation Snapshot

MetricValue
Total Patents116
Recent Applications3 (in the last year)
Invalid Patents8 (≈7%)
Internationalization4.1% of patents cross-border
Patent Value PositioningModerate

Technical Problems Solved

Top solved challenges include:

  • Even flow distribution in ventilators
  • Efficient gas exchange
  • Body fluid pathway optimization
  • FiO2 control (oxygen concentration)

React Health’s solutions focus on improving reliability and responsiveness in ventilation systems for both institutional and portable applications.

Innovation Matrix

Top Tech AreasApplication Domains
Type ventilators (23)Medical devices, gas treatment, respiratory masks
Oxygen gas (15)Tracheal tubes, carbon dioxide capture
Exsufflation (11)Diagnostic measuring, filtration systems
Oxygen concentratorsHealthcare management, semi-permeable membranes

React Health’s technology spreads across essential life-support systems, backed by R&D in medical breathing technologies and fluid handling mechanisms.

Global Technology Strategy

React Health shows a relatively high global footprint for a young company. About 4.1% of its patents were developed with cross-border R&D teams, indicating early steps toward international collaboration and global compliance.

Similar Companies

RankCompany NameSimilarity ScoreKey Shared Topics
1Fukuda Sangyo Co. Ltd.54.9%Oxygen gas, supply, respiratory function
2Beijing Yaguo Technology Co. Ltd.54.2%Exhalation, electrical stimulations, airflow
3Respironics, Inc.53.0%Sleep apnea, positive airway pressure, catheter
4Hunan Mingkang Zhongjin Medical Technology52.0%Breathing process, traffic volume, pressure sensor
5GaleMed Corp.49.8%Face masks, nose, respiratory devices

Innovation Strength Comparison

While React Health is in an early phase of growth, its patent value-to-citation ratio remains competitive. Compared with major incumbents like ResMed and BMC, React is steadily climbing the innovation curve with focused, valuable assets.

Subsidiary and Ownership Tree

React Health Holdings oversees Ventec Life Systems and related entities in the ventilator sector, extending its technology base through acquisitions and strategic IP consolidation.

Legal Status & Registration

FieldDetail
Legal NameReact Health Holdings, LLC
Entity Creation DateAugust 18, 2021
LEI Code254900P7CKRQFU7PNS66
RegistrationDelaware Division of Corporations, USA
Entity StatusActive
Next Renewal DateApril 29, 2026

Powered by Discovery & PatSnap Eureka AI Agent

The Patsnap Discovery offers a complete R&D intelligence suite to track, benchmark, and compare companies like React Health. It visualizes:

  • Top technical domains by patent volume
  • Key competitors and similarity metrics
  • Innovation gaps across applications
  • Technology maturity and expansion readiness

The PatSnap Eureka AI Agent further empowers professionals by:

  • Automatically extracting insights from IP and R&D data
  • Mapping competitors’ patent strength across domains
  • Validating design concepts with expert-level technical checks
  • Detecting whitespace for breakthrough innovation

Whether you’re a medtech investor or a market analyst, Eureka AI Agent delivers a clear edge in assessing companies like React Health Holdings.

Conclusion

React Health Holdings, LLC is rapidly building a meaningful footprint in ventilator and oxygen therapy systems. Though early in its lifecycle, its strong patent base, international innovation, and acquisition strategy signal long-term potential.

To explore deeper insights into React’s technology roadmap, visit the Patsnap Discovery and leverage PatSnap’s Eureka AI Agents for on-demand, expert-level analysis.

To get detailed scientific explanations of React Health Holdings, LLC, try Patsnap Eureka.

company profile Eureka
Share. Facebook Twitter LinkedIn Email
Previous ArticleThe Best AI Research Assistant for 2025
Next Article MBC FZ LLC Overview: Broadcasting & Media Services in the UAE

Related Posts

10 Emerging Graphene R&D Trends in 2025

September 5, 2025

When will a generic version of Entresto be approved in the United States?

August 15, 2025

Market Analysis of Prolia (Denosumab) in the USA

August 15, 2025

Market Analysis of Pomalyst (Pomalidomide) in the USA

August 14, 2025

When will a generic version of Keytruda (pembrolizumab) be launched?

August 14, 2025

Market Analysis of Lenalidomide in the USA

August 14, 2025

Comments are closed.

Start Free Trial Today!

Get instant, smart ideas, solutions and spark creativity with Patsnap Eureka AI. Generate professional answers in a few seconds.

⚡️ Generate Ideas →
Table of Contents
  • Company Overview
  • Technology Focus
  • Patent & Innovation Snapshot
  • Technical Problems Solved
  • Innovation Matrix
  • Global Technology Strategy
  • Similar Companies
  • Innovation Strength Comparison
  • Subsidiary and Ownership Tree
  • Legal Status & Registration
  • Powered by Discovery & PatSnap Eureka AI Agent
  • Conclusion
About Us
About Us

Eureka harnesses unparalleled innovation data and effortlessly delivers breakthrough ideas for your toughest technical challenges. Eliminate complexity, achieve more.

Facebook YouTube LinkedIn
Latest Hotspot

US20120251581A1 — Cyclophilin A and HCV Replicon Activity Dataset: Structure–Activity Relationship (SAR) and Biological Activity Analysis

June 3, 2026

Vehicle-to-Grid For EVs: Battery Degradation, Grid Value, and Control Architecture

May 12, 2026

TIGIT Target Global Competitive Landscape Report 2026

May 11, 2026
tech newsletter

35 Breakthroughs in Magnetic Resonance Imaging – Product Components

July 1, 2024

27 Breakthroughs in Magnetic Resonance Imaging – Categories

July 1, 2024

40+ Breakthroughs in Magnetic Resonance Imaging – Typical Technologies

July 1, 2024
© 2026 Patsnap Eureka. Powered by Patsnap Eureka.

Type above and press Enter to search. Press Esc to cancel.